Association between KRAS and PIK3CA Mutations and Progesterone Resistance in Endometriotic Epithelial Cell Line
Authors:
- Kosuke KannoKKKosuke Kanno
- Kentaro NakayamaKNKentaro Nakayama
- Sultana RaziaSRSultana Razia
- Sohel Hasibul IslamSohel Hasibul Islam
- Zahan Umme FarzanaZahan Umme Farzana
- Shahataj Begum SoniaShahataj Begum Sonia
- Hitomi YamashitaHYHitomi Yamashita
- Masako IshikawaMIMasako Ishikawa
- Tomoka IshibashiTITomoka Ishibashi
- Kayo ImamuraKIKayo Imamura
- Tohru KiyonoTKTohru Kiyono
- Satoru KyoSKSatoru Kyo
Open Access
- 19 April 2024
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 46 (4) , 3579-3594
Abstract
Although endometriosis is a benign disease, it is associated with cancer-related gene mutations, such as KRAS or PIK3CA. Endometriosis is associated with elevated levels of inflammatory factors that cause severe pain. In a previous study, we demonstrated that KRAS or PIK3CA mutations are associated with the activation of cell proliferation, migration, and invasion in a patient-derived immortalized endometriotic cell line, HMOsisEC10. In this study, we investigated the effects of these mutations on progesterone resistance. Since the HMOsisEC10 had suppressed progesterone receptor (PR) expression, we transduced PR-B to HMOsisEc10 cell lines including KRAS mutant and PIK3CA mutant cell lines. We conducted a migration assay, invasion assay, and MTT assay using dienogest and medroxyprogestrone acetate. All cell lines showed progesterone sensitivity with or without mutations. Regarding inflammatory factors, real-time quantitative RT-PCR revealed that the KRAS mutation cell line exhibited no suppression of Cox-2 and mPGES-1 on progesterone treatment, whereas IL-6, MCP-1, VEGF, and CYP19A1 were significantly suppressed by progesterone in both mutated cell lines. Our results suggest that KRAS mutation and PIK3CA mutation in endometriotic cells may not be associated with progesterone resistance in terms of aggressiveness. However, KRAS mutations may be associated with progesterone resistance in the context of pain.Keywords
Funding Information
- Japan Society for the Promotion of Science (21K09472, 22K09596)
This publication has 77 references indexed in Scilit:
- KRAS mutations and endometriosis burden of diseaseThe Journal of Pathology: Clinical Research, 2023
- Hormonal treatments for endometriosis: The endocrine backgroundReviews in Endocrine and Metabolic Disorders, 2021
- Endometriosis: Etiology, pathobiology, and therapeutic prospectsCell, 2021
- Classification of deep endometriosis (DE) including bowel endometriosis: From r-ASRM to #Enzian-classificationBest Practice & Research Clinical Obstetrics & Gynaecology, 2021
- Extra‐pelvic endometriosis: A reviewReproductive Medicine and Biology, 2020
- Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal EndometriumCell Reports, 2018
- Imbalance between sympathetic and sensory innervation in peritoneal endometriosisBrain, Behavior, and Immunity, 2012
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cellsFertility and Sterility, 2008
- Endometriosis: epidemiology and aetiological factorsBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- Two distinct estrogen‐regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.The EMBO Journal, 1990